Persistent Systems Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 29, 2025, 11:19 am

Competitors of Persistent Systems Ltd

All Competitor Stocks of Persistent Systems Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:10 am

Below is a detailed analysis of the quarterly data for Persistent Systems Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 3,242.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,062.00 Cr. (Dec 2024) to 3,242.00 Cr., marking an increase of 180.00 Cr..
• For Expenses, as of Mar 2025, the value is 2,658.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,524.00 Cr. (Dec 2024) to 2,658.00 Cr., marking an increase of 134.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 584.00 Cr.. The value appears strong and on an upward trend. It has increased from 538.00 Cr. (Dec 2024) to 584.00 Cr., marking an increase of 46.00 Cr..
• For OPM %, as of Mar 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 18.00%.
• For Other Income, as of Mar 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Dec 2024) to 18.00 Cr., marking a decrease of 25.00 Cr..
• For Interest, as of Mar 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Dec 2024) to 18.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 79.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 82.00 Cr. (Dec 2024) to 79.00 Cr., marking a decrease of 3.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 505.00 Cr.. The value appears strong and on an upward trend. It has increased from 482.00 Cr. (Dec 2024) to 505.00 Cr., marking an increase of 23.00 Cr..
• For Tax %, as of Mar 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 23.00% (Dec 2024) to 22.00%, marking a decrease of 1.00%.
• For Net Profit, as of Mar 2025, the value is 396.00 Cr.. The value appears strong and on an upward trend. It has increased from 373.00 Cr. (Dec 2024) to 396.00 Cr., marking an increase of 23.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 25.59. The value appears strong and on an upward trend. It has increased from 24.12 (Dec 2024) to 25.59, marking an increase of 1.47.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 3, 2025, 1:37 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 2:57 pm

Below is a detailed analysis of the balance sheet data for Persistent Systems Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 78.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 6,241.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,881.00 Cr. (Mar 2024) to 6,241.00 Cr., marking an increase of 1,360.00 Cr..
• For Borrowings, as of Mar 2025, the value is 311.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 451.00 Cr. (Mar 2024) to 311.00 Cr., marking a decrease of 140.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,107.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,963.00 Cr. (Mar 2024) to 2,107.00 Cr., marking an increase of 144.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 8,737.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,372.00 Cr. (Mar 2024) to 8,737.00 Cr., marking an increase of 1,365.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 2,614.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,221.00 Cr. (Mar 2024) to 2,614.00 Cr., marking an increase of 393.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 30.00 Cr..
• For Investments, as of Mar 2025, the value is 980.00 Cr.. The value appears strong and on an upward trend. It has increased from 827.00 Cr. (Mar 2024) to 980.00 Cr., marking an increase of 153.00 Cr..
• For Other Assets, as of Mar 2025, the value is 5,138.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,290.00 Cr. (Mar 2024) to 5,138.00 Cr., marking an increase of 848.00 Cr..
• For Total Assets, as of Mar 2025, the value is 8,737.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,372.00 Cr. (Mar 2024) to 8,737.00 Cr., marking an increase of 1,365.00 Cr..

Notably, the Reserves (6,241.00 Cr.) exceed the Borrowings (311.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Persistent Systems Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 91.22. This value is within the healthy range. It has increased from 72.44 (Mar 24) to 91.22, marking an increase of 18.78.
• For Diluted EPS (Rs.), as of Mar 25, the value is 90.24. This value is within the healthy range. It has increased from 71.07 (Mar 24) to 90.24, marking an increase of 19.17.
• For Cash EPS (Rs.), as of Mar 25, the value is 109.53. This value is within the healthy range. It has increased from 91.06 (Mar 24) to 109.53, marking an increase of 18.47.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 405.46. It has increased from 321.82 (Mar 24) to 405.46, marking an increase of 83.64.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 405.46. It has increased from 321.82 (Mar 24) to 405.46, marking an increase of 83.64.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 766.04. It has increased from 637.56 (Mar 24) to 766.04, marking an increase of 128.48.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 140.93. This value is within the healthy range. It has increased from 117.09 (Mar 24) to 140.93, marking an increase of 23.84.
• For PBIT / Share (Rs.), as of Mar 25, the value is 121.23. This value is within the healthy range. It has increased from 97.00 (Mar 24) to 121.23, marking an increase of 24.23.
• For PBT / Share (Rs.), as of Mar 25, the value is 116.93. This value is within the healthy range. It has increased from 93.97 (Mar 24) to 116.93, marking an increase of 22.96.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 89.84. This value is within the healthy range. It has increased from 70.98 (Mar 24) to 89.84, marking an increase of 18.86.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 89.84. This value is within the healthy range. It has increased from 70.98 (Mar 24) to 89.84, marking an increase of 18.86.
• For PBDIT Margin (%), as of Mar 25, the value is 18.39. This value is within the healthy range. It has increased from 18.36 (Mar 24) to 18.39, marking an increase of 0.03.
• For PBIT Margin (%), as of Mar 25, the value is 15.82. This value is within the healthy range. It has increased from 15.21 (Mar 24) to 15.82, marking an increase of 0.61.
• For PBT Margin (%), as of Mar 25, the value is 15.26. This value is within the healthy range. It has increased from 14.73 (Mar 24) to 15.26, marking an increase of 0.53.
• For Net Profit Margin (%), as of Mar 25, the value is 11.72. This value exceeds the healthy maximum of 10. It has increased from 11.13 (Mar 24) to 11.72, marking an increase of 0.59.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.72. This value is within the healthy range. It has increased from 11.13 (Mar 24) to 11.72, marking an increase of 0.59.
• For Return on Networth / Equity (%), as of Mar 25, the value is 22.15. This value is within the healthy range. It has increased from 22.05 (Mar 24) to 22.15, marking an increase of 0.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is 28.61. This value is within the healthy range. It has decreased from 28.79 (Mar 24) to 28.61, marking a decrease of 0.18.
• For Return On Assets (%), as of Mar 25, the value is 16.02. This value is within the healthy range. It has increased from 14.82 (Mar 24) to 16.02, marking an increase of 1.20.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.48. It has increased from 1.40 (Mar 24) to 1.48, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 2.36. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.36, marking an increase of 0.47.
• For Quick Ratio (X), as of Mar 25, the value is 2.36. This value exceeds the healthy maximum of 2. It has increased from 1.89 (Mar 24) to 2.36, marking an increase of 0.47.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 37.98 (Mar 24) to 0.00, marking a decrease of 37.98.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 29.61 (Mar 24) to 0.00, marking a decrease of 29.61.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 62.02 (Mar 24) to 0.00, marking a decrease of 62.02.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 70.39 (Mar 24) to 0.00, marking a decrease of 70.39.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 32.72. This value is within the healthy range. It has decreased from 38.60 (Mar 24) to 32.72, marking a decrease of 5.88.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 21.86. This value is within the healthy range. It has decreased from 24.40 (Mar 24) to 21.86, marking a decrease of 2.54.
• For Enterprise Value (Cr.), as of Mar 25, the value is 84,727.10. It has increased from 60,638.83 (Mar 24) to 84,727.10, marking an increase of 24,088.27.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.10. This value exceeds the healthy maximum of 3. It has increased from 6.17 (Mar 24) to 7.10, marking an increase of 0.93.
• For EV / EBITDA (X), as of Mar 25, the value is 38.58. This value exceeds the healthy maximum of 15. It has increased from 33.62 (Mar 24) to 38.58, marking an increase of 4.96.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.18. This value exceeds the healthy maximum of 3. It has increased from 6.26 (Mar 24) to 7.18, marking an increase of 0.92.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 62.01 (Mar 24) to 0.00, marking a decrease of 62.01.
• For Price / BV (X), as of Mar 25, the value is 13.57. This value exceeds the healthy maximum of 3. It has increased from 12.40 (Mar 24) to 13.57, marking an increase of 1.17.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.18. This value exceeds the healthy maximum of 3. It has increased from 6.26 (Mar 24) to 7.18, marking an increase of 0.92.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness